Skip to main content
logo
Noxopharm Limited (ASX:NOX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0490
0.00 (0.00%)
Oct 26, 2026, 12:43 PM AEDT

Noxopharm Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
152716191357
Market Cap Growth
-44.61%69.38%-18.18%53.49%-77.95%-69.35%
Enterprise Value
19311214141
Last Close Price
0.050.090.050.070.040.20

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
10.5518.735.598.042.0910.50
PB Ratio
--7.3322.873.511.392.36
P/TBV Ratio
--22.873.511.392.36

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
13.5521.644.115.890.247.48

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-1.25-1.253.59--0.01
Net Debt / Equity Ratio
-1.17-1.171.34-0.42-0.33-0.57
Net Debt / EBITDA Ratio
-1.25-1.25-0.170.500.291.46
Net Debt / FCF Ratio
-1.58-1.58-0.163.390.281.01
Asset Turnover
0.450.450.500.280.330.15
Inventory Turnover
-----10.67
Quick Ratio
0.330.331.163.799.458.43
Current Ratio
0.340.341.183.839.529.13
Return on Equity (ROE)
---157.93%-49.12%-90.72%-57.53%
Return on Assets (ROA)
-66.60%-66.60%-59.24%-34.01%-36.23%-16.42%
Return on Capital Employed (ROCE)
94.30%94.30%-757.40%-83.10%-116.10%-40.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-30.61%-16.67%-30.95%-18.55%-119.82%-32.76%
FCF Yield
-18.02%-10.15%-36.91%-3.55%-87.11%-24.10%
Buyback Yield / Dilution
-1.73%-1.73%---0.35%-10.37%